Product
Enriched Hematopoietic Stem Cell
1 clinical trial
1 indication
Indication
Kidney FailureClinical trial
Induction of Donor Specific Tolerance in Recipients of Living Kidney Allografts by Donor FCRx InfusionStatus: Terminated, Estimated PCD: 2023-03-01